Literature DB >> 645960

Evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia.

W H Berrettini, W H Vogel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 645960     DOI： 10.1176/ajp.135.5.605

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes.

Authors:  S Murphy; A Pastuszko
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

Review 2.  Genetics and schizophrenic behavior.

Authors:  E Kahn
Journal:  Psychiatr Q       Date:  1980

3.  Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.

Authors:  M A Reveley; V Glover; M Slander; A Coppen
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

4.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

Review 5.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.